Prof. Harald Neumann

Prof. Harald Neumann - Coordinator, Unniversitätsklinikum Bonn (UKB)

 

Prof. Harald Neumann is working at the University Hospital of Bonn, Germany

Visit his Lab-webpage or contact him

 

 

Work performed in PHAGO

“Our group is identifying CD33 receptor-related signalling pathways in microglia and analysing the function of human microglial CD33.”

 

  Interesting readings and/or reviews about our work

1) Publication suggests that TREM2 could have detrimental effects on neurons in aging mice without any disease process.
"TREM2 triggers microglial density and age-related neuronal loss".
Linnartz-Gerlach, B., Bodea, L.G., Klaus, C., Ginolhac, A., Halder, R., Sinkkonen, L., Walter, J., Colonna, M., Neumann, H. (2019). Glia.

 

2) Publication shows in an animal model of retinal laser lesion that local application of soluble polysialic acid  inhibits phagocytes and protects from vascular damage via the CD33-related SIGLEC11 receptor."
"Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retina."
Karlstetter, M., Kopatz, J., Aslanidis, A., Shahraz, A., Caramoy, A., Linnartz-Gerlach, B., Lin, Y., Lückoff, A., Fauser, S., Düker, K., Claude, J., Wang, Y., Ackermann, J., Schmidt, T., Hornung, V., Skerka, C., Langmann, T., Neumann, H. (2017). EMBO Mol Med
.

 

3) Publication demonstrates in culture that the CD33-related Siglec-E receptor turns down the neurotoxic oxidative burst of murine microglia.
"Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis associated oxidative burst."
Claude, J., Linnartz-Gerlach, B., Kudinm A.P., Kunz, W.S., Neumann, H. (2013). J Neuroscience

 

Prof. Harald Neumann
Prof. Harald Neumann
Prof. Jochen Walter
Prof. Jochen Walter
Prof. Guy Brown
Prof. Guy Brown
Dr Oliver Cousins
Dr Oliver Cousins
Tamara Raschka
Tamara Raschka
Mara Tornincasa
Mara Tornincasa
Paola Picardi
Paola Picardi
Dr Mona Mathews
Dr Mona Mathews
Home
Menu
Top
 

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115976. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies.

Social Media

PHAGO by Twitter PHAGO by LinkedIn

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115976. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and EFPIA companies.